The disnea in the EPOC;La disnea en la EPOC

Archivos de Bronconeumologia

Volumn 41, Issue SUPPL. 3, 2005, Pages 24-32

  Casanova Macario, C ^a,b   Garcia Talavera Martin I ^b   De Torres Tajes J P ^b  

^a CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APNEA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; HYPERCAPNIA; INSPIRATORY CAPACITY; INSPIRATORY RESERVE VOLUME; LUNG VOLUME; OXYGEN THERAPY; REVIEW; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

EID: 34547819345     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/s0300-2896(05)70742-0     Document Type: Review

References (72)

1. Barberà JA, Peces-Barba G, Agustí AG, Izquierdo JL, Monso E, Montemayor T, et al. Guía clínica para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2001;37:297-316.
2. Pawels R, Buist SA, Calverley P, Jenkins C, Hurd S. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-76.
3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
4. Marín JM, Carrizo SJ, Gascón M, Sánchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1395-9.
5. American Thoracic Society. Dyspnea: mechanisms, assessment, and management. A consensus statement. Am J Respir Crit Care Med. 1999;159:321-40.
6. Mahler DA, Jones PW. Measurment of dyspnea and quality of life in advanced lung disease. Clin Chest Med. 1997;18:457-69.
7. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnea scale as a measure of disability inpatients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-6.
8. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effect of pulmonary rehabilitation physiologic and pychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122:823-32.
9. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:785-90.
10. Celli BR. Monitoring the progression of chronic obstructive pulmonary disease: time for new staging system. Eur Respir Rev. 1999;9:165-8.
11. Canadian Thoracic Society. Recommendations for the management of chronic obstructive pulmonary disease. Can Respir J. 2003;10:11A-33A.
12. Celli BR, Cote C, Marín JM, Casanova C, Montes de Oca M, Méndez R, et al. The body mass index, airflow obstruction, dyspnea, exercise performance (BODE) index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005-12.
13. Perpiñá M, Martínez M. Disnea: bases fisiopatológicas, medición e implicación en la rehabilitación. En: Güell R, De Lucas P, editores. Rehabilitación respiratoria, Madrid: MMC; 1999. p. 39-59.
14. Marín JM. Manifestaciones clínicas: la disnea y su importancia en el paciente con EPOC. Arch Bronconeumol. 2001;37 Supl 1: 8-13.
15. Guz A. Brain, breathing and breathlessness. Respir Physiol. 1997;109:197-204.
16. De Lucas P, Rodríguez JM, López S. Disnea, calidad de vida y tolerancia al ejercicio. En: De Lucas P, Rodríguez González-Moro JM, editores. Biblioteca EPOC, diagnóstico y monitorización. Madrid: Ergón; 2004. p. 55-101.
17. Wasserman K, Casaburi R. Dyspnea: physiological and pathophysiological mechanisms. Annu Rev Med. 1988;39:503-15.
18. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care. 1996;153:967-75.
19. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003;124:1743-8.
20. Killian KJ, Jones NL. Respiratory muscles and dyspnea. Clin Chest Med. 1988;9:237-48.
21. LeBlanc P, Bowie DM, Summers E, Jones NL, Killian KJ. Breathlessness and exercise in patients with cardio-respiratory disease. Am Rev Respir Dis. 1986;133:237-48.
22. McCathie HCF, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J. 2002;19:47-53.
23. Schwartzstein RM, Simon JW, Weiss JW, Fenci V, Weinberger SE. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis. 1989;139:1231-7.
24. Schwartzstein RM, Manning HL, Weiss JW, Weinberger SE. Dyspnea: a sensory experience. Lung. 1990;168:185-99.
25. Widdicombe JG. Pulmonary and respiratory tract receptors. J Exp Biol. 1982;100:41-57.
26. Bolsher DC, Lindsey BG, Shannon R. Medullary inspiratory activity: influence of intercostal tendon organs and muscle spindle endings. J Appl Physiol. 1987;62:1046-56.
27. Bolsher DC, Lindsey BG, Shannon R. Respiratory pattern changes produced by intercostal muscle rib vibration. J Appl Physiol. 1988;84:1487-91.
28. nd ed. New York: Marcel Deckker; 1995. p. 473-510.
29. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strenght, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152:2021-31.
30. O'Donell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. Am Rev Respir Dis. 1993;148:1351-7.
31. Debigaré R, Coté CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms. Am J Respir Crit Care Med. 2001;164:1712-7.
32. Mahler DA, Jones PW, Guyatt GH. Clinical measurement of dyspnea. En: Mahler DA, editor. Dyspnea. New York: Marcel Dekker, Inc.; 1998. p. 149-81.
33. Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580-6.
34. Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;1:257-66.
35. Fletcher CM. Standarised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). Br Med J. 1960;2:1665.
36. Casanova C, Cote C, De Torres JP, Aguirre-Jaime A, Marín JM, Pinto-Plata V, et al. The inspiratory lung capacity ratio predicts mortality in patients with COPD. Am J Respir Crit Care Med. 2005;171:591-7.
37. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sport Exerc. 1982;14:377-81.
38. ATS Statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-7.
39. Mahler DA, Horowitz MB. Perception of breathlessness during exercise in patients with respiratory disease. Med Sci Sports Exerc. 1994;26:1078-81.
40. Aitken RCB. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62:989-93.
41. Mador MJ, Kufel TJ. Reproducibility of visual analog scale measurments of dyspnea in patients wtih chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;146:82-7.
42. Mcgavin CR, Artvinli M, Naoe H, Hardy GJR. Dyspnea, disability and distance walked. Comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978;2:241-3.
43. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85:751-8.
44. Archibald CJ, Guidotti TL. Degree of objectively measured impairment and perceived shortness of breath with activities of daily living in patients with chronic obstructive pulmonary disease. Can J Rehab. 1987;1:45-54.
45. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD (University of California, San Diego) Shortness of Breath Questionnaire. Chest. 1998;113:619-24.
46. Guyatt GH, Berman LB, Townshend M, Pugsley SO, Chambres LW. A measure of quality of life for clinical trials in chronic obstructive pulmonary disease. Thorax. 1987;42:773-8.
47. Lareau SC, Carrieri-Kohlman V, Janson-Bjerklie S, Ross PJ. Development and testing of the Pulmonary Functional Status and Dyspnea Questionnaire. Heart Lung. 1994;23:242-50.
48. De Torres JP, Casanova C, Hernández MC, Abreu J, Aguirre-Jaime A, Celli BR. Gender and chronic obstructive pulmonary disease in patients attending a pulmonary clinic. Chest. En prensa 2005.
49. PAARC Group Coopératif. Pollution atmosphérique et affections respiratoires chroniques ou á répétition. Bull Eur Physiopathol Respir. 1982;18:87-99.
50. Gift AG, Shepard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ? JOGNN. 1999;28:201-8.
51. Chapman KR, Tashkin DP, Pye D. Gender bias in the diagnosis of COPD. Chest. 2001;119:1691-5.
52. Agustí AGN. El síndrome de Lázaro o la EPOC resucitada. Arch Bronconeumología. 2001;37:3-6.
53. 1. Eur Respir J. 1999;14 Suppl 30:422.
54. Swinburn CR, Wakefield JM, Jones PW. Relationship between ventilation and breathlessness during exercise in chronic obstructive airway disease is not altered by prevention of hypoxemia. Clin Sci. 1984;67:146-9.
55. Stein DA, Bradley BL, Miller W. Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest. 1982;81:6-10.
56. O'Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation. Am J Respir Crit Care Med. 1995;152:2005-13.
57. Sibuya M, Yamada M, Kanamaura A, Tanaka K, Susuki H, Noguchi E, et al. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med. 1994;149:1235-40.
58. Campbell EJM, Friend J. Action of breathing exercises in pulmonary emphysema. Lancet. 1955;1:325-9.
59. O'Neill S, MaCarthy DS. Postural relief of dyspnea in severe chronic airflow limitation: relationship to respiratory muscle strength. Thorax. 1983;38:585-600.
60. O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832-40.
61. Ong KC, Kor AC, Chong WF, Earnest A, Wang YT. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169:1028-33.
62. Simon PM, Basner RC, Weinberger SE, Fencl V, Weiss JW, Schwartzstein RM. Oral mucosa stimulation modulates intensity of breathlessness induced in normal subjects. Am Rev Respir Med. 1991;144:419-22.
63. Broachard L. Non-invasive ventilation for acute exacerbations of COPD: a new standard of care. Thorax. 2000;55:817-8.
64. Keenan SP, Sinuff T, Cook DJ, Hill NS. Which patients with acute exacerbation of chronic obstructive pulmonary disease benefit from non-invasive positive-pressure ventilation? Ann Intern Med. 2003;138:861-70.
65. Casanova C, Celli BR, Tost L, Soriano E, Abreu J, Velasco V, et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest. 2000;118:1582-90.
66. Clini E, Sturani C, Rossi A, Viaggi S, Corrado A, Donner CF, et al. The italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur Respir J. 2002;20:529-38.
67. Wijkstra PJ, Lacasse Y, Guyatt GH, Carlisle CC, Casanova C, Gay PG, et al. A meta-analysis of nocturnal non-invasive positive pressure ventilation (NIPPV) in stable patients with chronic obstructive pulmonary disease (COPD). Chest. 2003;124;337-43.
68. Martínez FJ, Montes de Oca M, Whyte RI, Stez J, Gay S, Celli BR. Lung volume reduction improves dyspnea, dynamic hyperinflation and respiratory muscle function. Am J Respir Crit Care Med. 1977;155:1984-90.
69. Johnson MA, Woodcock AA, Geddes DM. Dihydrocodeine for breathless in pink puffers. Br Med J. 1981;283:343-6.
70. Massod AR, Reed JW, Thomas SH. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax. 1995;50:629-34.
71. Gift A, Moore T, Soeken K. Relaxation to reduce dyspnea and anxiety in COPD patients. Nurs Res. 1992;41:242-6.
72. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434-40.